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Encapsidation of nascent genome RNA into an RNase-resistant form by nucleocapsid protein, N is a necessary step in the rhabdoviral life
cycle. However, the precise mechanism for viral RNA specific yet processive encapsidation remains elusive. Using Chandipura virus as a model
system, we examined RNA binding specificity of N protein and dissected the biochemical steps involved in the rhabdoviral encapsidation process.
Our analysis suggested that N protein in its monomeric form specifically binds to the first half of the leader RNA in a 1:1 complex, whereas,
oligomerization imparts a broad RNA binding specificity. We also observed that viral P protein and dissociating detergent deoxycholate, both were
able to maintain N in a monomeric form and thus promote specific RNA recognition. Finally, use of a minigenome length RNA in an in vitro
encapsidation assay revealed the monomeric N and not its oligomeric counterpart, to be the true encapsidating unit. Based on our observations, we
propose a model to explain encapsidation that involves two discrete biochemically separable steps, initiation and elongation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Chandipura virus; Encapsidation; Leader RNA; Nucleocapsid protein; InitiationIntroduction
Rhabdoviruses in addition to being deadly human pathogens
are also responsible for causing epidemics in cattle, fish and
plant (Brown et al., 1979). Recent outbreaks of Chandipura
virus (Arankalle et al., 2005; Rao et al., 2004), a member of the
Rhabdoviridae family (Bhatt and Rodrigues, 1967), in parts of
India necessitates a detailed understanding of the viral
multiplication process, both for better therapeutic intervention
as well as for providing a general model system to understand
the rhabdovirus life cycle. Chandipura virus packages an 11,119
nucleotide long nonsegmented, negative sense genome RNA,
enwrapped with viral nucleocapsid protein (N) into a ribonu-
cleoprotein (RNP) particle (Marriott, 2005). The genome of the
Chandipura virus encodes for 5 polypeptides in the order 3′-N-
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doi:10.1016/j.virol.2006.01.017sequences of ∼50 bases, 3′leader (l) and 5′trailer (t) (Banerjee,
1987). Viral RNA-dependant RNA polymerase (RdRp) is
composed of large protein (L, 238.5 kDa) bearing the catalytic
activity and the 32 kDa phosphoprotein (P), which acts as its
cofactor (Banerjee and Barik, 1992). The encapsidated genome
RNA is resistant to RNase action and acts as the template for
RNA polymerization. Subsequent to viral infection, RdRp
initiates transcription at the 3′end of the viral genome to
sequentially synthesize leader RNA and 5 monocistronic
mRNAs with progressive attenuation at each gene junction
(Abraham and Banerjee, 1976; Iverson and Rose, 1981). During
replication, the same polymerase reads through the stop signal
at gene boundaries to produce a polycistronic complement of
genome RNA, which acts as the template for subsequent
synthesis of progeny viral genomes (Banerjee, 1987; Wertz and
Levine, 1973). The molecular switch that leads to a change in
polymerase function has remained an enigma for rhabdoviruses.
Polymerase, with distinct compositions engaged in transcription
or replication process has been proposed (Qanungo et al., 2004).
Differential engagement of cis-acting elements in transcription
or replication has also been postulated (Li and Pattnaik, 1997;
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transcriptase complex at the promoter for N gene (Chuang and
Perrault, 1997). Furthermore, previous work on VSV (Banerjee
and Barik, 1992; Richardson and Peluso, 1996) or Chandipura
system (Basak et al., 2003, 2004; Chattopadhyay et al., 1997)
led to identification of phosphoprotein phosphorylation as a
major determinant for polymerase function. While CKII-
mediated phosphorylation at Ser62 of Chandipura virus P
protein is indispensable for transcription (Chattopadhyay et al.,
1997), a phosphorylation-defective mutant of P was shown to
boost up viral replication presumably by its ability to bind to
nascent leader RNA (Basak et al., 2003).
Nonetheless, a requirement for de-novo protein synthesis
was reported during the viral replication process (Davis and
Wertz, 1982; Patton et al., 1983; Wertz, 1983; Wertz and
Levine, 1973). Interestingly, on-going synthesis of N protein
was shown to satisfy this requirement in an in vitro replication
assay (Patton et al., 1984). Accordingly, it was suggested that
N-mediated nucleation and progressive encapsidation of
nascent leader chain result in anti-termination at the gene
boundaries that eventually leads to the onset of the replication
process (Blumberg et al., 1981, 1983; Leppert et al., 1979).
Although, this model does not exclude the possibility of
synergistic involvement of other host factors or viral compo-
nents, it advocates the need for encapsidation competent N
during replication. Furthermore, a stoichiometric amount of N is
necessary for encapsidation, to protect newly synthesized
genome RNA from cellular RNase action. Thus, N-mediated
encapsidation of nascent (+) sense genome that initiates at
leader sequence signifies a critical event in viral multiplication
process. However, N protein of vesiculoviruses had been
consistently found to self-assemble into inactive aggregates
when expressed in mammalian cell or in E. coli (Das and
Banerjee, 1993; Howard and Wertz, 1989; Majumder et al.,
2004; Patton et al., 1983). This aggregated form of N protein
although capable of interacting with leader RNA lacks the
ability to encapsidate 129nt long (+) sense VSV RNA into an
RNase-resistant form (Moyer et al., 1991). Moreover, these
aggregates were shown to interact with nonviral RNAs when
expressed in the cell (Green et al., 2000; Iseni et al., 1998).
Interestingly, phosphoprotein inhibits the concentration-depen-
dent aggregation of N and it was believed that complex
formation between N and P was one of the ways of maintaining
a pool of replication competent N (Howard and Wertz, 1989). P
protein was found to act as a specific chaperone that acts at the
nucleation step to prevent N protein aggregation (Majumder et
al., 2001, 2004). Accordingly, multiple N–P complexes of
various molar ratios were observed within VSV-infected cells
(Davis et al., 1986; Masters and Banerjee, 1988a; Peluso, 1988;
Peluso and Moyer, 1988) or when coexpressed in E. coli (Green
et al., 2000; Gupta and Banerjee, 1997). Furthermore, P was
shown to suppress nonspecific RNA binding ability of N
protein without interfering with leader RNA recognition by N
(Masters and Banerjee; 1988b). Though P could not revert
presynthesized N into a form that is suitable for encapsidation
(Majumder et al., 2004; Masters and Banerjee, 1988a), prior
complex formation with P was found to be a prerequisite forspecific recognition of viral sequences. Thus, it was hypothe-
sized that P protein channels N protein towards nascent viral
leader sequence within the infected cell to ensure successful
encapsidation of de novo synthesized viral genome. Nonethe-
less, aggregation prone characteristics so far prohibited detailed
biochemical characterization for different modes of RNA
binding by N protein in vitro. Although, when coexpressed
with P in E. coli, a soluble form of vesicular stomatitis virus N
protein was obtained as an N–P complex (Green et al., 2000),
lack of a homogeneous N preparation hindered studies on
properties of N protein complexes upon P binding.
Previously, we had reported the expression of recombinant
Chandipura virus N protein in bacteria and its purification in a
soluble form that is capable of RNA binding (Majumder et al.,
2001). Here, we show that consistent with aggregation prone
characteristics, affinity-purified N exists mostly in an oligo-
meric form. Treatment with dissociating detergent, such as
deoxycholate, results in a pool of predominantly monomeric N
protein, which, unlike oligomeric N, specifically recognizes
viral leader RNA in vitro. The monomer N-leader RNA
complex is shown to be biochemically distinct from a higher
order N–RNA complex. Furthermore, competition gel shift
assay and toe-printing analysis revealed that monomeric N
binds within the first half (20 nucleotides) of leader RNA that is
highly conserved among different vesiculoviruses. We found
that P protein, independent of its phosphorylation status,
maintains N protein in a monomeric form, thus mimicking
deoxycholate action. Moreover, we show that this N–P complex
and not N alone is a prerequisite for processive encapsidation of
597 nucleotides viral sequence into an RNase-resistant form in
vitro. Accordingly, a mechanism elucidating the specific yet
processive encapsidation of viral RNA by N protein has been
discussed, in the context of the Chandipura virus life cycle.
Results
N protein can form two complexes with leader RNA in vitro
To understand the mechanism for specific viral RNA binding
by Chandipura virus Nucleocapsid protein, N, we used a
previously described soluble preparation of recombinant N in an
RNA binding assay (Majumder et al., 2001). Accordingly, in
vitro synthesized radiolabeled leader RNA was incubated with
N protein and the RNA–protein complexes were resolved
through native gel (Materials and methods). Fig. 1A shows
formation of high molecular weight complex upon incubation
of N protein with leader RNA (lane2), where the intensity of the
shifted band progressively increased with an increasing gradient
of N (lanes 2–7). Subsequently, we examined RNA binding
ability of N protein by EMSA in the presence of a variety of
salts or detergents to elucidate the biochemical nature of the
RNA–protein interaction. As reported earlier (Iseni et al.,
2000), we found the N–RNA complex to be modestly salt-
sensitive due to its ionic nature (data not shown). Surprisingly,
pretreatment of N protein with a mild ionic detergent,
deoxycholate (DOC) at two different concentrations (0.5%
and 1%) revealed an additional faster migrating complex
Fig. 1. N protein forms two different complexes with leader RNA in vitro. (A) The ability of purified recombinant N protein to encapsidate leader RNA in vitro was
tested by electrophoresis mobility shift assay (EMSA). In vitro synthesized radiolabeled leader (l*) RNAwas incubated in 1× binding buffer either alone (lane 1) or in
the presence of increasing N protein concentrations as indicated (lanes 2 to 7), at 37 °C for 15 min. Complexes were resolved through a 4% native PAGE. (B) To test
detergent sensitivity of RNA binding ability of N protein, l*-RNA probe was incubated with 3 μg of N protein as in panel A (lane 2) or after prior treatment with two
different concentration (0.5% and 1%) of deoxycholate (DOC) (lanes 3 and 4) or NP-40 (lanes 5 and 6) for 10 min in binding buffer at 37 °C before loading on a native
gel. (C) N protein was incubated simultaneously with l*RNA and 0.3%, 0.5% and 1% DOC (lanes 1, 2 and 3, respectively) for 15 min as usual and the complexes were
resolved through a native gel.
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order N–RNA complex (complex I) (Fig. 1B, lanes 3–4).
Furthermore, nonionic detergent NP-40 was unable to elicit
such a change in the oligomeric status of N–RNA complexes
(lanes 5–6), suggesting a specific mechanism underlying DOC-
action. Pretreatment with as low as 0.3% DOC was sufficient
for complete abrogation of higher order N–RNA complex and
formation of complex II (data not shown). Furthermore,
increasing concentration of DOC, added during formation of
the N–RNA complex, results in formation of the faster
migrating complex II exclusively (Fig. 1C). These results
indicate that the formation of complex II might be directly
dependent on the disruption of N–N interaction, solely
attributed to the probable action of DOC to prevent N protein
oligomerization without affecting its leader RNA recognition
ability.
Deoxycholate induces a change in the oligomeric status of N
protein
Previously, we described self-aggregation property of N
protein, where a gradual increase in the hydrated diameter of
N protein was observed in complete absence of detergents
over a period of 24 h. Presence of mild detergent, such as
Triton X-100, was shown to partly prevent this self-
aggregation process (Majumder et al., 2001). As treatmentwith dissociating detergents, such as DOC, results in
formation of a unique faster migrating N–RNA complex, we
sought to examine any potential alterations in the oligomeric
status of N protein itself, upon DOC-treatment. To this end,
affinity-purified N protein either alone or after treatment with
1% DOC was subjected to gel filtration chromatography
through a Sephacryl S-300 column (Fig. 2A). Accordingly,
different fractions were collected, absorbance was measured at
280 nm and molecular weight was estimated assuming a
globular solution behavior for N protein in its different
oligomeric forms (Materials and methods). As depicted in Fig.
2A, majority of the N protein (closed circle) elutes in the 27th
fraction, with an estimated molecular weight of approximately
250 kDa. DOC treatment results in a change in the elution
profile with majority of N (open circle) eluting in fraction 52
as a monomer protein, with an estimated molecular weight of
45 kDa. This result indicates a change in the oligomeric status
of N protein upon treatment with dissociating ionic detergent,
which probably interferes with N–N interaction and thus
maintains N protein in a monomeric form.
Additionally, we carried out sucrose density gradient
centrifugation to examine sedimentation properties of N protein
in the absence or presence of detergent. N protein, either
untreated or treated with 1% DOC, was loaded on a 10%–60%
preformed sucrose gradient and alternate fractions were
subjected to SDS-PAGE followed by silver staining (Fig. 2B).
Fig. 2. Deoxycholate induces a change in the oligomeric status of N protein. (A) Size exclusion chromatography. Purified preparation of N protein in the presence
(open circle) or absence (closed circle) of 1%DOC was analyzed by gel filtration chromatography on a Sephacryl S-300 column (1.5 × 45 cm) equilibrated in binding
buffer at 4 °C. Elution profile of N and N-DOC is expressed as the relative absorbance at 280 nm. Arrows indicate the elution position of protein molecular weight
standards with known molecular weights, used to calibrate the column-A: Ferritin (440 kDa), B: Catalase (232 kDa), C: BSA (67 kDa) and D: Ovalbumin (45 kDa).
Above: Calibration graph of the column obtained from the elution profiles of protein standards. The estimated molecular weights of untreated (N) and DOC-treated (N-
DOC) N protein were determined by comparing their Ve/Vo ratios with the calibration graph. (B) Silver-stained 10% SDS-PAGE profile of alternate fractions of
purified N protein either alone or treated with 1% DOC after fractionation through a preformed 10–60% sucrose step gradient by centrifugation at 32,000 rpm for 16
h at 4 °C. Arrows below the gels indicate sedimentation positions of standard proteins with known sedimentation coefficients, run in parallel; Carbonic anhydrase (2.9
S), BSA (4.6 S), Catalase (11.4 S) and Ferritin (18 S). (C) Fractions from the previous sucrose gradient designating both untreated (fraction 10–12) and DOC-treated
(fraction 16–18) N protein (lanes 1 and 2, respectively) were pooled separately, mixed with native dye and loaded onto a 6% native PAGE, run at 4 °C in native buffer.
The gel was stained with Coomassie Brilliant Blue R-250.
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from the bottom of the gradient. However, detergent treatment
results in a population of slower sedimenting N, which could be
found in fractions 16–18. Elution of a higher order N assembly
in an identical position to 232 kDa protein Catalase as an 11.5 S
particle in sucrose gradient (Fig. 2B, upper panel), along with
the previous gel filtration results further suggests that N may
form a pentamer in solution. Importantly, DOC-treated N elutes
as a 3 S particle along with ovalbumin (45 kDa), thus
confirming existence of monomeric N upon detergent treatment
(Fig. 2B, lower panel). Finally, we separately pooled either N
protein eluted in fraction 10–12 or detergent-treated N protein
eluted in fraction 16–18, concentrated them and loaded the two
fractions on a 6% native PAGE. The untreated N protein
migrated near the top of the gel as a conglomeration of closely
spaced bands as earlier reported for VSV (Masters and
Banerjee, 1988b) while DOC-treated proteins entered into the
gel as a single faster migrating band (Fig. 2C). These results in
conjunction with our previous analysis suggest that DOC
promotes formation of monomeric N protein by disruptingoligomeric assemblies. While oligomeric N protein showed
certain heterogeneity on native gel, it apparently revealed
characteristics of defined complex on gel filtration analysis.
Therefore, it seems likely that subtle conformational heteroge-
neity could exist within oligomeric N population that is
otherwise identical in terms of subunit composition.
Stoichiometry of different N–RNA complexes
Deoxycholate prevents N protein oligomerization and keeps
it in the monomeric form. Accordingly, RNA binding analysis
revealed presence of a faster migrating N-leader RNA complex
in the presence of detergent. These results suggest a possible
change in the stoichiometry of N–RNA complex upon DOC
treatment. To investigate this possibility, we examined the
number of N molecules bound per leader RNA utilizing gel
filtration and sucrose density gradient centrifugation assays.
Radiolabeled leader RNA was incubated with either N protein
alone or N pretreated with DOC as described (Materials and
methods). Subsequently, the complexes were resolved through a
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RNA elution profile was monitored by Cerenkov counting of
each fraction as a measure for complex elution. Consistently, we
observed two distinct peaks for the DOC-treated (open circles)
and untreated (closed circles) sets indicating the presence of two
stable RNA–protein complexes, separable with respect to their
molecular weights (Fig. 3A). Estimated molecular weight for
complex I was found to be ∼300 kDa suggesting that five
molecules of N protein bind to RNA to form the higher order
complex. In contrast, the radioactivity peak was observed to
coelute with BSA in the presence of DOC, indicating a
molecular weight of 67 kDa. This implies that one N binds to
leader RNA to form the intermediate complex II. Leader-RNA
alone eluted at a different position sufficiently separated from
that of either complexes (not shown).
Next, we examined the N protein–leader RNA complexes by
sucrose density gradient centrifugation. While some free N
protein unassociated with RNA eluted as protein oligomer in
10–12 fraction, as observed before, the higher order complex I
was exclusively found in the 6th fraction from the bottom of the
gradient as evident from the coelution of N protein and labeled
RNA (Fig. 3B, panel i). This gives a sedimentation value of∼18
S for the higher order complex that corroborates with previous
findings by Blumberg and Kolakofsky (1981). Nonetheless,
separate elution profile for oligomeric N and RNA-bound
oligomer also confirms our N preparation, per se, to be free from
any endogenous bacterial RNA. Complex II formed in the
presence of DOC, however, sediments predominantly in ∼14th
fraction with an S value of ∼4.6, suggesting the presence of aFig. 3. (A) N protein either untreated (closed circle) or treated with 1% DOC for 30
RNA and incubated in binding buffer for 30 min. The resulting complexes were loa
elution profile was monitored by Cerenkov counting and expressed as counts per m
weight standards—A: Ferritin (440 kDa), B: Catalase (232 kDa), C: BSA (67 kDa) a
RNA complexes. The l*RNA–N protein complexes, both untreated and treated wit
sedimented through 10–60% sucrose gradients in binding buffer by ultracentrifugation
were analyzed through 10% SDS-PAGE for the presence of RNA–protein complexes.
shown to give an estimate of the elution profile of α 32P-UTP-labeled RNA and pro
Carbonic anhydrase (2.9 S), BSA (4.6 S), Catalase (11.4 S) and Ferritin (18 S).molecular species of 67 kDa, composed of one N molecule and
an RNA (Fig. 3B, panel ii). These results along with gel filtration
analysis, thus confirm a change in the stoichiometry of N–RNA
complex upon DOC treatment, concomitant with a DOC-
induced disruption of protein oligomer.
Complex II is different from the leader RNA encapsidation
complex
The higher order RNA–protein complex consisting of
oligomeric N formed an encapsidation complex that was
irreversible and resistant to RNase (Basak et al., 2003;
Majumder et al., 2001). We asked if an RNA–protein complex
consisting of DOC-treated N retained such characteristics. To
test RNase sensitivity, leader RNA was incubated with N
protein in the absence or presence of deoxycholate. Subse-
quently, the preformed complexes were treated with RNaseA
prior to loading on a native gel. Unlike complex I, monomeric
N–RNA complex was found to be RNase sensitive with
complete loss of shifted band upon RNase treatment (Fig. 4A,
compare lanes 3 and 4). When preformed N-labeled leader RNA
was challenged with excess unlabeled leader RNA, only a
minor decrease in the shifted band intensity was observed
implying that the higher order N–RNA complex formation was
irreversible (Fig. 4B, lanes 1–4). However, complex II formed
in the presence of DOC was found to be reversible in nature.
Addition of 2–10-fold molar excess of unlabeled leader RNA to
preformed complex II results in proportional decrease in the
shifted band intensity within 10 min of cold RNA additionmin (open circle) was mixed with α32P-UTP-labeled in vitro synthesized leader
ded on a Sephacryl S-300 column equilibrated in the same buffer at 4 °C. RNA
inute for each 1 ml fraction. Arrows represent the elution of protein molecular
nd D: Ovalbumin (45 kDa). (B) Sedimentation analysis of the N protein–leader
h DOC (i and ii, respectively), were formed essentially as in gel filtration and
as mentioned earlier. Alternate fractions, collected from the bottom of the tubes,
Both autoradiographic impressions as well as silver staining of the same gels are
tein in the complexes. Sedimentation of protein standards is marked by arrows:
Fig. 4. Complex II is different from the leader RNA encapsidation complex. (A) To test the RNase sensitivity of two complexes, N protein, either untreated (lane 1) or
pretreated for 10 min with 1% DOC (lane 3), was incubated with l*RNA probe. The two complexes thus formed were additionally incubated for 10 min with RNaseA
(final concentration 60 μg/ml) (lanes 2 and 4, respectively). (B) To check for the differential mode of interaction, complexes I and II were formed essentially as
mentioned earlier (lanes 1 and 5). The preformed complexes were challengedwith 2-fold (lanes 2 and 6), 5-fold (lanes 3 and 7) or 10-fold (lanes 4 and 8) molar excess of
cold leader RNA for another 10min before loading onto a 4%native gel. (C) For the protease sensitivity experiment, complexes I (lane 1) and II (lane 4)were treatedwith
either Proteinase-K (lanes 2 and 5) or Trypsin (lanes 3 and 6) for 10 min and resolved through gels. *Indicates the altered position of complex I upon protease treatment.
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unlabeled leader (Fig. 4B, lanes 5–8). Furthermore, we checked
protease sensitivity of preformed complexes I and II by partial
digestion of RNA–protein complexes with Proteinase K or
Trypsin. Complex I showed resistance towards both the
proteases as evident from the formation of slightly faster
migrating encapsidation complex on a native gel (Fig. 4C, lanes
1–3). This could be due to digestion of a protease-sensitive
region of N protein in higher order RNA–protein complex
leaving a protease-resistant core of the protein still bound to
leader RNA. This result is complementary to the finding of Iseni
et al. (1998) who showed that Trypsin cleaved a 17 kDa fragment
of rabies virus N protein without altering the overall nucleo-
capsid structure. Complex II, on the contrary, was susceptible to
both Proteinase K and Trypsin treatment (lanes 4–6). Therefore,
this observation indicates that the nucleocapsid structure confers
protease resistance to N protein, while in the absence of any
protein–protein interaction (i.e. in presence of DOC), N protein
is sensitive to protease action, even in RNA-bound form.
N monomer recognizes a specific sequence element in the
leader RNA
Our present analysis shows that N protein can interact with
leader RNA both as an oligomer or monomer, albeit differently,forming distinct complexes. Previous studies from our group in
the Chandipura virus system and also by other researchers have
consistently shown that N protein possesses a nonspecific RNA
binding activity (Basak et al., 2003; Masters and Banerjee,
1988b). In this context, we asked if nonspecific RNA binding
ability of N protein is intrinsic to individual N polypeptide or an
acquired trait arising from protein multimerization. To this end,
N protein without additional treatment with DOC was incubated
with an increasing gradient of unlabeled leader RNA (lanes 2–
4, Fig. 5A), leader RNA (1–21) (lanes 5–7, Fig. 5A), unrelated
tRNA (lanes 8–10) or unrelated RNA derived from pGEM3z
vector (lanes 11–13). Subsequently, radiolabeled leader RNA
was added to the reaction mixture prior to resolving the
complexes in a native gel (Materials and methods). Our
competition gel shift analysis revealed that leader RNA binding
could be efficiently competed by unlabeled RNA of viral or
nonviral origin as evident from complete absence of shifted
band intensity, demonstrating the nonspecific RNA binding
ability of oligomeric N (Fig. 5A). This result suggests that
oligomeric N utilizes a single site with broad RNA recognition
specificity for complex I formation thus allowing competition
by nonviral RNA. Interestingly, DOC-treated N protein was
able to form the complex II even in the presence of 2–5-fold
molar excess of cold unrelated tRNA (Fig. 5B, lanes 8–10) or
nonviral RNAs similar in size to leader, using either pGEM3z
Fig. 5. Monomer N-leader RNA interaction is specific in nature. (A and B) N protein either alone (A) or after treatment with 1%DOC (B) was incubated in buffer alone
(lane 1) or in the presence of equal (lanes 2, 5, 8 and 11), 2-fold (lanes 3, 6, 9 and 12) and 5-fold (lanes 4, 7, 10 and 13) molar excess of cold leader, first half of leader
l (1–21), tRNA and a 3z vector derived nonviral RNA, respectively, in binding buffer at 37 °C for 15 min. The specificity of complex II formation was also tested in the
presence of similar molar excesses of either pET3a-derived nonviral RNA of comparable base composition to leader (B, lanes 14–16) or the second half of leader
l (24–45) (B, lanes 17–19). The reaction mixtures were chased with l*RNA probe for 10 min and resolved through a 4% native PAGE.
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RNA of similar base composition (lanes 14–16). Viral leader
sequence and more importantly leader (1–21) efficiently
compete with the labeled probe for the complex II formation
(lanes 2–7). These results indicate the presence of a distinct
virus-specific RNA recognition motif in monomeric N, which
could not be saturated by even 5-fold molar excess of nonviral
RNA. However, saturation of this specific RNA binding motif
by unlabeled leader RNA (1–21) indicates that a specific cis-
acting sequence present in the first half of the leader could be
responsible for complex formation between monomeric N and
leader RNA. Interestingly, the first 24 nucleotides of the leader
RNA contain high sequence homology among different
rhabdoviruses (Marriott, 2005) and were shown to be necessary
for efficient encapsidation and genome replication (Li and
Pattnaik, 1997). Moreover, the second half of leader RNA (24–
45) could not chase out the complex II (Fig. 5B, lanes 17–19),
further indicating that the first half of the leader is responsible
for N monomer binding. From these data, it also appears that
oligomerization of N protein compromises its RNA binding
specificity, presumably by masking specific RNA recognition
motif and creating additional altered surface of broader
specificity at the expense of specific RNA binding domain.
Subsequently, we performed toe-printing analysis on leader
RNA bound to N protein monomer to define specific target
sequence of monomeric N. For this purpose, we utilized an inFig. 6. N monomer recognizes a specific sequence element in the leader RNA. (A
Autoradiogram of a 8% sequencing gel showing inhibition of extension reaction from
(Chpl-T7) (lane 1) or after incubation with N protein that is untreated (lane 2) or treate
was used in binding reaction (lanes 3 to 5). FT is the signal corresponding to the full l
14 nt less than FT. Lanes G, A, T and C correspond to the individual sequencing rea
primer to determine the nucleotide bases of interaction. (B) To test possible interactio
encompassing trailer sequence (lane 1) was incubated with N, untreated or DOC-trea
native PAGE.vitro synthesized 70 nt long leader RNA with a fusion of
additional 21 residues at the 3′end of 49 nt leader sequence
(Materials and methods). We also designed a primer that anneals
to the extended 3′end sequence of leader RNA and produces a
70 nt long cDNA product in reverse transcription reaction (lane
1, Fig. 6A). Subsequently, leader RNA, bound to N protein in
the absence or presence of DOC, was annealed with the primer
and reverse transcribed. Binding of N oligomer to leader
interfered with primer annealing and thus no cDNA product was
obtained (lane 2). However, RNA present in the complex II
could be partially copied to form a cDNA product, suggesting
the presence of a block at the 14th residue, mediated by the
specific binding of N monomer on the leader RNA (lane 3) that
inhibits cDNA elongation. Furthermore, intensity of the
inhibited cDNA product increased in a manner that is dependent
on the concentration of deoxycholate treated N (lanes 3–5).
The trailer region positioned at the extreme 5′end of the
genome RNA shows a high degree of complementarity to the
leader sequence. The encapsidation process is initiated on the
(+) sense leader sequence during formation of the viral
replication intermediate, the positive strand genome. During
the synthesis of progeny negative strand genome RNAs from
the replication intermediate, RNA synthesis and consequently
encapsidation begin from the trailer sequence. We tested, if (−)
trailer is also a substrate for specific binding by monomeric N
protein. To this end, trailer sequence cloned under T7 promoter) Toeprint analysis of the formation of initiation complex for encapsidation.
a γ-32P end-labeled primer PE1 on in vitro synthesized CHP virus leader RNA
d with DOC (lane 3). An increasing concentration gradient of 1%DOC treated N
ength reverse transcript, arrow indicates the position of the major toeprint signal,
ctions with respective ddNTPs, performed on free Chpl-T7 RNAwith the same
n between trailer sequence and N protein, in vitro synthesized radiolabeled RNA
ted (lanes 2 and 3, respectively). Subsequently, complexes were resolved on 4%
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(Materials and methods). Gel shift analysis revealed that N
protein both as oligomer or monomer was able to form distinct
complexes with trailer RNA, thus, resembling leader RNA
binding (Fig. 6B). Our competition gel shift experiments
revealed that unlabeled trailer RNA efficiently competes with
leader as well as trailer probe for virus-specific RNA binding
region of monomeric N (data not shown).
P protein maintains majority of N in the monomer form in vitro
The DOC-mediated disruption of oligomeric form of N
protein demonstrated the monomeric status to be an important
prerequisite for the specific interaction of N with l-RNA. So we
questioned whether the P protein of CHP virus could substitute
the in vitro action of DOC in keeping N in a predominantly
monomeric form. In our experimental condition, we were
unable to disrupt oligomeric or higher aggregates of N proteins,
once formed, into monomer by incubation with P (data not
shown). Therefore, we used detergent-dissociated N monomer,
dialyzed against a deoxycholate free buffer in the absence or
presence of P protein, to examine the ability of P to keep N as a
monomer. After dialysis, the protein samples were loaded on
sucrose density gradient to test any possible change in the
oligomeric status of the N protein. Upon DOC removal in
absence of P, N protein eluted in fraction 10–12 similar to that
of untreated oligomer, thus implying detergent dissociation of
N-oligomer to be a reversible process. However, an equimolar
mixture of N and P protein formed upon DOC dialysis revealed
most of the N protein to be present as a slower sedimenting
particle coeluting with P protein as a complex (Fig. 7, bottom
panel). The elution profile of the N–P complex in sucrose
gradient with peak elution in fraction 14–16 closely matches
that of DOC-treated monomeric N, thus implying maintenance
of N in monomer form by P protein in solution, possibly in a 1:1
complex. We also noticed that a minor amount of N oligomer
coelutes with P in fraction 4 as a faster sedimenting higher orderFig. 7. P protein maintains majority of N in the monomeric form. Purified N
protein was treated with 1%DOC for 30 min as mentioned earlier. Subsequently,
DOC was dialyzed out over night against TET/150 mM NaCl, either in the
absence or presence of equimolar amount of P protein. The DOC dialyzed N or
N–P complexes (N-DOC and N–P DOC, respectively) were layered on top of a
preformed 10–60% sucrose gradient in the same buffer and sedimented by
ultracentrifugation as described. Fractions collected from the bottom were
analyzed through silver staining of a (30:0.4) 10% SDS-PAGE. Purified N and P
proteins were run in parallel to provide an estimate of their differences in
migration. The protein standards are marked by arrows.complex (bottom panel). In addition, we used FITC-labeled N
protein and incubated with P in presence of DOC. Subsequently,
detergent was removed by dialysis, the reaction mixture was
resolved by gel filtration and the elution profile of N was
monitored by measuring the emission at 520 nm. Chromato-
graphic separation methods revealed similar results, viz, a
predominant pool of N was maintained in a lower molecular
weight form in the presence of P protein (data not shown).
N protein maintained in a monomer form by P can encapsidate
viral sequences in a specific yet processive manner
P protein was shown to form complexes with nascent N
synthesized in reticulocyte lysate in vitro to prevent the binding
of vesicular stomatitis virus N protein with nonviral RNA
(Masters and Banerjee, 1988b). However, a higher order N–P
complex formed by coexpressing N and P protein in E. coli was
shown to be associated with ∼90 nt long bacterial RNA (Green
et al., 2000). In this context, we sought to examine RNA
binding specificity of N oligomer or monomer N–P complexes
purified through sucrose gradient. For this purpose, radiola-
beled ∼65 nt long nonviral RNA derived from pGEM3z vector
was incubated with N oligomer or N–P complexes (Fig. 8A) in
the presence of increasing amount of unlabeled leader RNA
(lanes 3–4 and 6–7) and the reaction mixtures were resolved
through a native gel. As reported earlier, oligomeric N was able
to bind to nonviral RNA forming a higher order complex (lane
2), while N–P complex did not recognize pGEM3z derived
RNA sequences (lane 5). Furthermore, excess unlabeled leader
RNA could be shown to compete for this nonspecific RNA
binding by N oligomer (lanes 3–4), which further indicates that
a single site on N-oligomer is utilized for both leader RNA
binding and interaction with nonviral RNA (discussed later).
Nonetheless, we confirm that Chandipura virus N protein in a
1:1 complex with P is identical to DOC-disrupted monomeric N
in that it does not recognize nonviral sequences.
Although, aggregated N protein was shown to form RNase-
resistant complexes with leader RNA (Blumberg et al., 1983), it
was unable to encapsidate longer VSV RNA in vitro (Moyer et
al., 1991). Based on our observations, it seems likely that
oligomeric N bound to short leader RNA sterically hinders the
nuclease action. In contrast, the longer transcripts remain RNase
sensitive possibly due to inability of the oligomer to properly
enwrap the RNA. However, it may also be possible that N
oligomer does form a true encapsidation complex on leader
sequence but a viral or host factor plays an essential role in
continuation of the encapsidation process after a finite length.
Preparation of N protein in a 1:1 complex with P, that preserves
N as a monomer, provided an opportunity to directly address the
encapsidation competency of this monomeric form. To this end,
stoichiometric amount of leader RNA was incubated with
oligomeric N (fraction 10–12) or purified N–P complex
(fraction 14–16), from the sucrose gradients. Subsequently,
complexes were treated with RNase, protected RNAwas phenol
extracted, ethanol precipitated and examined on a 10%
denaturing urea PAGE. As depicted in Fig. 8B, N protein in a
monomeric form complexed with P was equally proficient in
Fig. 8. N monomer–P complex encapsidates viral sequences in a specific yet processive manner. (A) P provides specificity to the RNA binding ability of N. NS*RNA
(lane 1) was incubated in 1× binding buffer with DOC dialyzed N or N–P either alone (lanes 2 and 5, respectively) or in the presence of 2.5-fold (lanes 3 and 6) or 5-
fold (lanes 4 and 7) molar excess of specific cold l-RNA before resolving the complexes through a 4% native gel. (B and C) RNase protection assay was performed
with N (lanes 3 and 4) or N–P complexes (lanes 5 and 6) after DOC dialysis and in vitro synthesized leader RNA (B) or lNt genome RNA (C). The RNA–protein
complexes were allowed to form as usual. Subsequently, RNase (200 μg/ml final concentration) was added to the reaction mixture and the digestion was stopped by
Proteinase-K addition after 15 min. The protected RNAs were viewed by ethidium bromide staining of the respective gels—10% urea PAGE for the l-RNA (B) and 1%
agarose gel for lNt genome RNA (C). A control RNA lane without protein and the corresponding digestion pattern are shown for both the cases (lanes 1 and 2,
respectively). (D) The protected RNA products of lNt genome RNA before and after interaction with DOC dialyzed N protein and subsequent RNase treatment were
run on a 4% agarose gel and viewed similarly. Arrows correspond to the protected RNA products.
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implying encapsidation of viral sequence by N–P complex in
our assay condition. However, protein binding to these short
transcripts (∼50 nt) may prevent RNase action by multiple
mechanisms, which could be independent of true enwrapment
of bound RNA by protein units. Hence, we utilized the RNase
protection assay to examine processive encapsidation of longer
transcripts that resemble viral genome termini. To this end, we
first cloned a 597 nt fragment from the 3′end of Chandipura
genome under the control of T7 promoter in pGEM3z vector
and in vitro synthesized (+) sense lNt genome RNA (Materials
and methods). Subsequently, genome lNt RNA (Fig. 8C) was
incubated with DOC dialyzed N (lanes 3–4) or N–P complex
(lanes 5–6). RNA alone or RNA–protein complexes were
treated with RNaseA and protected RNA was run on a 1%
agarose gel. As depicted in Fig. 8C, the N oligomer was unable
to protect mini-genome length RNA from RNase action (lanes
3–4). However, discrete bands of ∼50 to 200 nucleotides were
observed on 4% agarose gel after RNase treatment (Fig. 8D,
lane 4), reflecting the ability of the N-oligomer to provide
protection to RNA of finite length. Interestingly, proper
encapsidation of genome lNt RNA in the presence of N–P
complex into an RNase-resistant structure was revealed by its
ability to offer complete protection of the genome like fragment(compare lanes 5 and 6, Fig. 8C). These results indicate that
monomeric N protein present in a P-bound form retains two
important characteristics of the true encapsidating macromol-
ecule, namely, its ability to recognize a specific site on leader
sequence (nucleation) and its power to ensure processive
enwrapment of genome length RNA into an RNase-resistant
form (elongation). Current analysis also indicates that oligo-
meric N binds to RNA nonspecifically and can protect bound
RNA from RNase action only up to a finite length, in a way that
is not dependent on true encapsidation.
Discussion
While one major function of N is to protect genome RNA
from RNase action, processive encapsidation was proposed to
modulate polymerase activity in the replication phase (Gubbay
et al., 2001). How N protein recognizes critical sequences on
nascent viral genome within infected cell and continues to
progressively encapsidate a 11.2-kb genome RNA into a mature
nucleocapsid structure remains poorly understood. N protein of
Chandipura virus, similar to its VSV counterpart, lacks any
knownRNA recognitionmotif in its amino acid sequence, which
implies possible involvement of novel RNA recognition modes
in the encapsidation process. Although, the last five amino acids
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genome encapsidation (Das et al., 1999), it is currently unclear
how N protein acquires specific yet processive encapsidation
capability. Nonetheless, self-association tendency presented
difficulty in obtaining adequate amount of N for its biochemical
characterization. Over-expression in E. coli resulted in a form of
N protein that was insoluble except in high salt (Das and
Banerjee, 1993). Although coexpression with P protein main-
tained N in a soluble form, it resulted in a higher order N–P
complex that bound bacterial RNA nonspecifically (Green et al.,
2000). We were able to optimize an expression condition for
Chandipura virus N protein that allowed us to obtain
homogeneous N protein in a soluble oligomeric form (Majumder
et al., 2001). Although, our purified N preparation was free from
any cellular RNA (Majumder et al., 2004), it had the ability to
interact with nonspecific RNA in gel shift assays.We believe ion
exchange-based purification protocol resulted in dissociation of
any bacterial RNA from our N preparation during high salt
elution steps. Consistent to this notion, we observed rapid
dissociation of N–RNA complex upon salt treatment by EMSA
although this interaction is stable when competed with unlabeled
RNA, implying formation of a complex that is stabilized through
ionic interaction. However, consistent with prior reports, this
form of the N protein sedimented rapidly in density gradients as
demonstrated in Fig. 2B and was able to form higher order
complexes with leader RNA (Howard and Wertz, 1989). The
leader RNA bound to oligomeric N is resistant to RNase action
and sediments as a ∼18 S particle similar to the authentic
encapsidation complexes previously observed for VSV (Blum-
berg et al., 1981, 1983). When tested with a 597-nt long RNA
that was identical to (+) ve sense genome fragment derived from
the 5′end of the Chandipura genome intermediate (Figs. 8C and
D), the oligomeric N, however, was incapable of encapsidating
RNA into an RNase-resistant structure beyond a certain length
(∼50–200 nt). This observation prompted us to define the true
encapsidating unit that can ensure specific yet processive
encapsidation.
Previous studies with VSV-defective interfering particle
revealed that the 5′terminal 36 nucleotides and 3′terminal 51
nucleotides of the genome are sufficient for VSV-DI replication,
encapsidation and budding of the virus like particles (Pattnaik et
al., 1995). In vitro assembly of synthetic nucleocapsid identified
the first 19 nt from the 5′end of the (+) sense RNA to be
necessary and sufficient for processive encapsidation (Moyer et
al., 1991). The same set of studies revealed that heterologous
sequences, when fused downstream to the first 19 authentic
nucleotides, supported encapsidation as efficiently as viral
sequences, demonstrating compromised specificity in the
ensuing encapsidation process although enwrapment reportedly
follows a distinct pattern that requires one N molecule per 9
nucleotides of RNA (Thomas et al., 1985). We utilized a
dissociating detergent, deoxycholate, to disrupt oligomeric N
into monomeric form (Fig. 2) and dissected specific as well as
general RNA recognition modes of N. Gel filtration and sucrose
density gradients showed that the monomeric N forms 1:1
RNA-bound complex in the presence of DOC that is
distinguishable from higher order complexes. However, asdepicted in Fig. 5B, the most intriguing RNA binding property
of monomeric N is its specificity towards viral leader sequence,
particularly the first ∼20 nt of the (+) ve sense genome.
Interestingly, the trailer sequence, representing the 5′terminus
of (−) ve sense genome and which is complementary to and has
high sequence homology with leader RNA, was also recognized
specifically by the monomer. The monomeric N bound to
specific nucleation site on the first half of the leader RNA was
unable to recruit additional N molecules to form encapsidation
complexes in the presence of DOC, revealing discrete
requirement for N–N association in the ensuing encapsidation
process. To the best of our knowledge, this is the first
biochemical demonstration of intrinsic RNA binding specificity
of a rhabdoviral monomeric N protein. This RNA binding
specificity of N is, however, compromised upon formation of N-
oligomer (Fig. 8A). Moreover, these results indicate that
encapsidation process might be a biochemically separable
biphasic event; the initiation or nucleation phase involves
specific recognition of conserved sequences present in the first
half of the leader chain while processive encapsidation or
elongation phase ensures enwrapment of heterogeneous
sequences into the nucleocapsid particle.
Phosphoprotein P acts as an N-specific chaperone by
preventing nascent N protein from growing into insoluble
aggregates (Majumder et al., 2004). Moreover, nonspecific
RNA binding ability of N was suppressed in the presence of P,
though the mechanism remained unclear (Masters and Banerjee,
1988b). We developed an in vitro system that allowed us to
form complexes between P protein and monomeric N, as well as
to test the RNA binding specificity of such complexes. We
noticed that such a complex prevented N from binding to
nonspecific RNA unlike a higher order N–P complex isolated in
a bacterial RNA-bound form (Green et al., 2000). One critical
difference between N–P complex studied by Green et al. and
our group is, however, the different subunit composition;
bacterially isolated coexpressed N–P complex is an assembly of
decameric N as compared to the N monomers in the N–P
complex of our preparation (Fig. 7). Thus, it seems likely that P
protein modulates RNA binding specificity of N by keeping it in
a monomeric form, therefore, playing an essential role in
ensuring supply of replication competent or in other words
encapsidation-competent N during the viral replication stage.
N-oligomer, once formed, apparently retains its ability to
interact with nonviral RNA even in the presence of P protein,
which is unable to either disrupt this oligomer assembly or mask
the nonspecific RNA recognition domain. Interestingly, Fig.
8 showed that the N monomer–P complex, unlike DOC-treated
N, not only interacted but also formed higher order encapsida-
tion complexes with leader RNA. Furthermore, N monomer -P
complex and not N-oligomer, showed the ability to enwrap and
protect minigenome length viral RNA in vitro, thus resembling
the behavior of a true encapsidating entity in vivo.
Based on our analysis, we provided a refinement of the
existing hypothesis to explain mechanistic pathway involved in
the encapsidation process. In this model, N protein as such,
possesses specific RNA recognition domain in its primary
structure, while oligomerization alters the RNA binding surface
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property for N-oligomer. Oligomeric N, stabilized through N–N
association possibly into a pentamer assembly, is capable of
enwrapping short RNA of viral or cellular origin into an
encapsidation-like structure so as to deny nuclease accessibility,
as shown previously by our group (Majumder et al., 2001). The
stable oligomer while bound to RNA was unable to coopera-
tively recruit additional oligomer units on the leader chain.
However, N protein present in a monomeric form can recognize
specific cis-acting signal in the leader chain, a prerequisite for
nucleation. Subsequently, N protein polymerization on RNA
chain relies on a substitution reaction whereby P protein is
released from N monomer–P complex as N associates with the
phosphate backbone of the RNA, protecting it from RNase
action. However, inhibition of N–N association resulted in
abrogation of this elongation phase suggesting critical involve-
ment of N–N association either prior or simultaneous to N–
RNA binding. Accordingly, we noticed cooperativity in the N
monomer–leader RNA interaction when encapsidation was
studied in vitro in the absence of detergent (unpublished data).
Additional interactions between RNA bound and free N during
further recruitment of N moiety in the adjacent sequences
primarily generate an altered RNA binding surface that may
recognize a broad spectrum of RNA sequences, a prerequisite
for processive encapsidation or elongation phase. While a fast
reversible interaction between N and P protein ensures supply
of monomeric N protein requirements during nucleation
process, N–N as well as N–RNA association traps additional
N molecule in an RNA-bound form in the elongation phase.
Consistent with this model, it was observed that N formed
multiple complexes with P (Davis et al., 1986; Masters and
Banerjee, 1988a) and the slowest sedimenting form was
implicated as the substrate for replication and encapsidation
(Peluso and Moyer, 1988). This model allowed us to explain the
previously found intimate relationship between encapsidation,
N protein aggregation, P-mediated specificity in N protein
action as well as requirement of coexpressed P protein in viral
replication process. Although, additional viral peptides, such as
M protein or host factors, may play an essential role in
maturation of encapsidation complexes into a higher order
condensed RNP particle during late stages of virion assembly, it
seems that defined viral components, N and P, are necessary and
sufficient for presenting genomic sequences into an RNase-
resistant form. Mutagenic analysis on N protein to dissect
oligomerization, P binding as well as RNA binding will shed
further light on the precise steps in Chandipura virus assembly
pathway. Accordingly, screening of natural or synthetic small
molecules that disrupts interaction between monomeric N with
its cognate RNA sequence may provide novel therapeutic
intervention in viral infection process.
Materials and methods
Materials
Oligonucleotides used in this study were purchased from
Operon Technologies, USA. The column materials used for ionexchange or gel filtration chromatography were from Amer-
sham Biosciences (Uppsala, Sweden). All restriction enzymes
were from NEB. Protein molecular weight standards were
purchased from Sigma (St. Louis, MO). Cell culture reagents
were from Gibco-BRL (Gaithersburg, MD). Radioactive
biomolecules were purchased from BRIT, India. All other
chemicals were of analytical grade.
Cell culture and virus
CHP virus (Strain 1653514) was purified from BHK-21 cells
grown in DMEM supplemented with 5% calf serum by
infection with virus at an m.o.i. of 0.1 (Basak et al., 2003).
Cloning of a 597-nt fragment (lNt) from the 3′end of the viral
genome
Genomic RNAwas isolated from purified Chandipura virus
using Tripure reagent (Roche) according to manufacturer's
protocol. Viral RNA (500 ng) and sense primer (25 pmol) (3′
1chp1-5′-agagaattcacgaagacaaaaaaaccatttaaacgattatat-3′) that
anneals to the 3′termini of the viral genome were heated
together at 85 °C for 10 min and immediately placed on ice.
Subsequently, reverse M-MuLV transcriptase (Roche) was
added in cDNA synthesis buffer and the mixture was incubated
at 42 °C for 1 h. RT product was used for PCR amplification
with Pwo polymerase (Roche) and 3′1chp1-DJC2 primer set
according to manufacturer's instructions and the products were
analyzed in a 1% agarose gel. DJC2 corresponds to N gene
downstream primer (5′-tttataggatcctcatgcaaagag-3′). The leader
to N PCR product was digested with EcoRI to give an lNt
fragment (encompassing the leader sequence – intragenic gene
junction – and N gene coding sequence up to the 541st
nucleotide) that was cloned into an EcoRI linearized pGEM3z
vector. Positive clones were confirmed through restriction
digestion.
Bacterial expression and purification of N and P proteins
N protein was over-expressed from pET3a NC clones in E.
coli (BL21DE3) cells and purified from the soluble cell lysate
fraction by anion exchange chromatography using Mono-Q
FPLC column with a sodium chloride gradient of 200 mM to
700 mM in TET buffer (Majumder et al., 2001). Purification of
recombinant P protein was carried out essentially as mentioned
earlier (Basak et al., 2003). All recombinant proteins were
concentrated with Centricon protein concentrators (Amicon)
and checked in SDS-PAGE. Quantitations were made with BIO-
RAD DC assay reagents.
Synthesis of RNA probes
Positive sense leader RNA, 65 nt long nonviral RNA, trailer
RNA, l–1 (1– 21 nucleotides of the leader RNA) and l–2 RNA
(24–45 nucleotides of the l-RNA) used in gel shift assays were
obtained as mentioned earlier (Basak et al., 2003, 2004). The
unrelated pET3a RNA used in the competition gel shift assay
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NdeI using T7 RNA polymerase and was similar in length and
base composition to leader RNA (A–T composition: 66% in
comparison to 69% of leader). In vitro synthesized RNA was
eluted from urea-polyacrylamide gels, precipitated twice with
ethanol and suspended in RNase free water. Radioactivity was
measured in liquid scintillation counter. RNAs used in this
study were quantified spectrophotometrically by their absor-
bance at 260 nm. The positive sense lNt genome RNA used in
the RNase sensitivity assay was synthesized from pGEM3z/lNt
construct linearized with XbaI using T7 RNA polymerase
(Bangalore Genei, India). For primer extension, the leader gene
was cloned into pGEM4z vector using overlapping primers as
mentioned (Basak et al., 2003). The reverse primer, 3′lchp2-T7,
contained a 16-nt tag of the T7promoter sequence at its 5′end
just after the HindIII site (5′-agaaagctttatagtgagtcgtattgtgttcgtg-
tactactatataatcgtttaa-3′). pGEM4z/CHPl-T7 was linearized with
HindIII and the RNAwas in vitro synthesized using SP6 RNA
polymerase (Roche). Cold RNAwas gel eluted and precipitated,
before using in binding reactions with protein.
Electrophoretic mobility shift assay (EMSA)
EMSA of radiolabeled leader, nonviral or trailer RNA
(60,000 cpm) with N protein was carried out in binding buffer
as mentioned earlier (Basak et al., 2003) or first the N protein
was treated with various concentrations of deoxycholate (DOC)
or NP40 in binding buffer for 10 min before incubating with
RNA.
For reversibility gel shift analysis, labeled probe was
incubated with protein. The preformed complexes were then
chased with indicated amount of unlabeled RNAs for 10 min
and then loaded onto the gels. Competition assay was
performed similarly, except that indicated unlabeled RNA was
added to protein prior to radiolabeled probe addition. For the
RNase or Proteinase protection experiments, first the N–RNA
complexes were allowed to form and then treated with RNase or
Proteinase at a final concentration of 60 μg/ml. The incubation
was carried out for additional 10 min before resolving through
gels. All the EMSA experiments were run on 4% native gels
containing 5% glycerol, at 4 °C in 1× TAE.
Gel filtration analysis
Gel exclusion chromatography was carried out in a
Sephacryl S-300 column (45 × 1.5 cm) equilibrated with
binding buffer (10 mM Tris, 40 mM KCl, 1 mM DTT, 10 mM
MgCl2 and 100 mM NaCl) at 4 °C. Sample loading volumes
were kept at 300 μl and constant flow rate (0.2 ml/min) was
maintained by a peristaltic pump. Void volume of the column
was determined by monitoring the elution profile of blue
dextran (20 ml). To determine the oligomeric status of N
protein, ion exchange-purified N protein either directly or after
treating with 1%DOC for 30 min at RTwas loaded onto the pre-
equilibrated column at a concentration of 0.4 mg/ml. Protein
elution was monitored by taking O.D. 280 values of the 1 ml
fractions collected and plotted against their respective elutionvolumes. For determination of stoichiometry of RNA to protein
in the initiation and encapsidation complexes, N protein either
as it is or after pretreatment with 1%DOC was incubated with
radiolabeled leader RNA in binding buffer for 30 min prior to
loading onto the column pre-equilibrated in the same buffer at 4
°C. One-milliliter fractions were collected. We ensured that the
peaks of either RNA or N protein alone did not coincide with
the RNA–protein peaks in either case. Elution of RNA was
monitored by Cerenkov counting and the radioactivity present
in each fraction, expressed in counts per minutes (cpm), was
plotted against elution volumes (ml). Five independent gel
filtration experiments were carried out for each set. The column
was calibrated by running protein standards of known molecular
weights-Ferritin (450 kDa), Catalase (232 kDa), BSA (67 kDa)
and Ovalbumin (45 kDa). Standard protein elution was
expressed as Kav and plotted against respective log molecular
weight values. Kav was calculated from the formula: (Ve − Vo) /
(Vt − Vo), where Ve is the eluted volume, Vo is the void volume
and Vt is the total volume. Molecular weights of the DOC
treated and untreated oligomeric forms of N protein as well as
the RNA–protein complexes were determined from the
calibration curve.
Sucrose density gradients
Each 10 ml 10–60% sucrose step gradients was prepared in
gradient buffer (50 mM Tris (pH 8), 1 mM EDTA, 0.1%
TritonX-100 and 150 mM NaCl). Samples of ion exchange-
purified N protein (0.4 mg/ml) before and after treatment with
1% DOC were layered on top of the gradient in a volume not
exceeding 150 μl. The gradients were centrifuged for 16 h at
32,000 rpm in an SW Ti 40 Beckman rotor at 4 °C. Following
centrifugation, 0.5-ml fractions were collected from the bottom
of the gradients. The proteins from each alternate fraction were
precipitated by acetone and run in (30:0.8) 10% SDS-PAGE.
Proteins were visualized by silver staining. Sedimentation
coefficients were determined by comparing with protein
standards-Carbonic anhydrase (2.9 S), BSA (4.6 S), Catalase
(11.4 S) and Ferritin (18 S), run in parallel gradients and detected
identically. For determination of the two N–RNA complexes,
first the complexes were allowed to form as described in gel
filtration and fractionated through sucrose gradients (in binding
buffer). Protein was detected through silver staining while the
radiolabeled RNAwas visualized through autoradiography. For
the N–P experiments, DOC-treated N proteins were dialyzed
over night against gradient buffer in the absence or presence of
equimolar amount of P protein. The resulting protein complexes
in both cases were run in gradients. Proteins were detected in
10% SDS-PAGE composed of 30:0.4 acrylamide:bisacrylamide
for separation of N and P, which migrates anomalously to a 50-
kDa position in 30:0.8 SDS gels.
Toeprinting assay
Toeprinting analysis of the initiation complex was performed
with + sense leader RNA and primer PE1 (5′-tatagtgagtcgtatt-
3′), 5′end-labeled with T4 Polynucleotide Kinase (Promega,
210 R. Bhattacharya et al. / Virology 349 (2006) 197–211WI, USA) and γ-32P ATP (4500 Ci/mmol) according to the
manufacturer's instructions. Reaction components were assem-
bled in a similar manner to the gel shift assay with minor
variations. Briefly, 0.2 μg of leader RNA was incubated in
binding buffer with 1.5–2 μg of N protein or with 1% DOC-
treated N at different concentrations (0.5–2 μg) for 30 min at 37
°C in a total volume of 10 μl. Incubation was continued at 65 °C
for 5 min after addition of end-labeled PE1 (10 pmol). Initiation
complex formation was analyzed by primer extension using
MMuLV reverse transcriptase at 42 °C for 30 min. The cDNA
products were mixed with denaturing dye (95% deionized
formamide, 0.025% (w/v) bromophenol blue, 0.025% xylene
cyanol, 5 mM EDTA and 0.025% SDS), boiled at 95 °C for 5
min and resolved through an 8% sequencing gel. The products
were compared with the ladder generated on the leader RNA
with the same primer. Sequencing reactions were carried out in a
similar manner where only ddNTPs (Promega) instead of
dNTPs were used on the leader RNA template.
RNase sensitivity assay
Leader and lNt RNAs, in vitro transcribed frompGEM3zCHPl
and pGEM3z/lNt plasmids, respectively, were used as templates
for encapsidation by N protein. RNA (5–7.5 μg) was used for
encapsidation studies with 50–100 μg N protein. N protein used
for this assaywas incubated with 1%DOC andDOCwas dialyzed
out in the absence and presence of P protein as mentioned earlier.
Preformed complexes were digested with RNaseA at a final
concentration of 200 μg/ml for 15 min at 37 °C. The RNase
reaction was quenched by adding Trypsin (100 μg/ml) and the
digested products were extracted by phenol–chloroform and
precipitated in 100% ethanol. After resuspension in RNase free
water, the protected leader and lNt genomeRNAswere viewed by
ethidium bromide staining of 10%urea PAGE or 1% and 4%
agarose gels, respectively.
Acknowledgments
RB acknowledges CSIR, Govt. of India, for providing Senior
Research Fellowship. SB thanks Alexander Hoffmann, UCSD,
USA for his support. We acknowledge Siddhartha Roy of the
Indian Institute of Chemical Biology, India for discussions and
critical comments; Rajarshi Ghosh, AECOM, USA and Arpita
Bhattacharya, Calcutta University, India for critical reading of
the manuscript. This work was supported by DST, Govt. of
India.
References
Abraham, G., Banerjee, A.K., 1976. Sequential transcription of the genes of
vesicular stomatitis virus. Proc. Natl. Acad. Sci. U.S.A. 73, 1504–1508.
Arankalle, V.A., Shroti, S.P., Madhukar, W.A., Hanumaih, P.S., Dattatraya, M.
A., Chandra, G., 2005. N and P gene-based analysis of Chandipura viruses,
India. Emerging Infect. Dis. 11, 123–126.
Banerjee, A.K., 1987. Transcription and replication of rhabdoviruses. Micro-
biol. Rev. 51, 66–87.
Banerjee, A.K., Barik, S., 1992. Gene expression of vesicular stomatitis virus
genome RNA. Virology 188, 417–428.Basak, S., Raha, T., Chattopadhyay, D., Majumder, A., Shaila, M.S.,
Chattopadhyay, D.J., 2003. Leader RNA binding ability of Chandipura
virus P protein is regulated by its phosphorylation status: a possible role in
genome transcription–replication switch. Virology 307, 372–385.
Basak, S., Polley, S., Basu, M., Chattopadhyay, D., Roy, S., 2004. Monomer and
dimer of Chandipura virus unphosphorylated P-protein binds leader RNA
differently: implications for viral RNA synthesis. J. Mol. Biol. 339,
1089–1101.
Bhatt, S., Rodrigues, F.M., 1967. Chandipura virus: a new arbovirus isolated
from India from patients with febrile illness. Ind. J. Med. Res. 55,
1295–1305.
Blumberg, B.M., Kolakofsky, D., 1981. Intracellular vesicular stomatitis virus
leader RNAs are found in nucleocapsid structures. J. Virol. 40, 568–576.
Blumberg, B.M., Leppert, M., Kolakofsky, D., 1981. Interaction of VSV leader
RNA and nucleocapsid protein may control VSV genome replication. Cell
23, 837–845.
Blumberg, B.M., Giorgi, C., Kolakofsky, D., 1983. N protein of vesicular
stomatitis virus selectively encapsidates leader RNA in vitro. Cell 32,
559–567.
Brown, F., Bishop, D.H., Crick, J., Francki, R.I., Holland, J.J., Hull, R.,
Johnson, K., Martelli, G., Murphy, F.A., Obijeski, J.F., Peters, D., Pringle, C.
R., Reichmann, M.E., Schneider, L.G., Shope, R.E., Simpson, D.I.,
Summers, D.F., Wagner, R.R., 1979. Rhabdoviridae. Report of the
Rhabdovirus Study Group, International Committee on Taxonomy of
Viruses. Intervirology 12, 1–7.
Chattopadhyay, D., Raha, T., Chattopadhyay, D.J., 1997. Single serine
phosphorylation within the acidic domain of Chandipura virus P protein
regulates the transcription in vitro. Virology 239, 11–21.
Chuang, J.L., Perrault, J., 1997. Initiation of vesicular stomatitis virus mutant
polR1 transcription internally at the N gene in vitro. J. Virol. 71, 1466–1475.
Das, T., Banerjee, A.K., 1993. Expression of the vesicular stomatitis virus
nucleocapsid protein gene in Escherichia coli: analysis of its biological
activity in vitro. Virology 193, 340–347.
Das, T., Chakraborti, B.K., Chattopadhyay, D., Banerjee, A.K., 1999. Carboxy-
terminal five amino acids of the nucleocapsid protein of vesicular stomatitis
virus are required for encapsidation and replication of genome RNA.
Virology 259, 219–227.
Davis, N.L., Wertz, G.W., 1982. Synthesis of vesicular stomatitis virus negative-
strand RNA in vitro: dependence on viral protein synthesis. J. Virol. 41,
821–832.
Davis, N.L., Arnheiter, H., Wertz, G.W., 1986. Vesicular stomatitis virus N and
NS proteins form multiple complexes. J. Virol. 59, 751–754.
Green, T.J., Macpherson, S., Qiu, S., Lebowitz, J., Wertz, G.W., Luo, M., 2000.
Study of the assembly of vesicular stomatitis virus N protein: role of the P
protein. J. Virol. 74, 9515–9524.
Gubbay, O., Curran, J., Kolakofsky, D., 2001. Sendai virus genome synthesis
and assembly are coupled: a possible mechanism to promote viral RNA
polymerase processivity. J. Gen. Virol. 82, 2895–2903.
Gupta, A.K., Banerjee, A.K., 1997. Expression and purification of vesicular
stomatitis virus N–P complex from Escherichia coli: role in genome RNA
transcription and replication in vitro. J. Virol. 71, 4264–4271.
Howard, M., Wertz, G., 1989. Vesicular stomatitis virus RNA replication: a role
for the NS protein. J. Gen. Virol. 70, 2683–2694.
Iseni, F., Barge, A., Baudin, F., Blondel, D., Ruigrok, R.W.H., 1998.
Characterization of rabies virus nucleocapsids and recombinant nucleocap-
sid-like structures. J. Gen. Virol. 79, 2909–2919.
Iseni, F., Florence, B., Blondel, D., Riogrok, R.W.H., 2000. Structure of the
RNA inside the vesicular stomatitis virus nucleocapsid. RNA 6, 270–281.
Iverson, I.E., Rose, J.K., 1981. Localized attenuation and discontinuous
synthesis during vesicular stomatitis virus transcription. Cell 23, 477–484.
Leppert, M., Rittenhouse, L., Perrault, J., Summers, D.F., Kolakofsky, D., 1979.
Plus and minus strand leader RNAs in negative strand virus-infected cells.
Cell 18, 735–747.
Li, T., Pattnaik, A.K., 1997. Replication signals in the genome of vesicular
stomatitis virus and its defective interfering particles: identification of a
sequence element that enhances DI RNA replication. Virology 232,
248–259.
Majumder, A., Basak, S., Raha, T., Chowdhury, S.P., Chattopadhyay, D., Roy,
211R. Bhattacharya et al. / Virology 349 (2006) 197–211S., 2001. Effect of osmolytes and chaperone-like action of P-protein on
folding of nucleocapsid protein of Chandipura virus. J. Biol. Chem. 276,
30948–30955.
Majumder, A., Bhattacharya, R., Basak, S., Shaila, M.S., Chattopadhyay, D.J.,
Roy, S., 2004. P-protein of Chandipura virus is an N-protein specific
chaperone that acts at the nucleation stage. Biochemistry 43, 2863–2870.
Marriott, A.C., 2005. Complete genome sequence of Chandipura and Isfahan
Vesiculoviruses. Arch. Virol 150 (4), 671–680.
Masters, P.S., Banerjee, A.K., 1988a. Resolution of multiple complexes of
phosphoprotein NS with nucleocapsid protein N of vesicular stomatitis
virus. J. Virol. 62, 2651–2657.
Masters, P.S., Banerjee, A.K., 1988b. Complex formation with vesicular
stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein
N to nonspecific RNA. J. Virol. 62, 2658–2664.
Moyer, S.A., Smallwood-Kentro, S., Haddad, A., Prevec, L., 1991. Assembly
and transcription of synthetic vesicular stomatitis virus nucleocapsids. J.
Virol. 65, 2170–2178.
Pattnaik, A.K., Ball, L.A., LeGrone, A., Wertz, G.W., 1995. The termini of VSV
DI particle RNAs are sufficient to signal RNA encapsidation, replication,
and budding to generate infectious particles. Virology 206, 760–764.
Patton, J.T., Davis, N.L., Wertz, G.W., 1983. Cell-free synthesis and assembly of
vesicular stomatitis virus nucleocapsids. J. Virol. 45, 155–164.
Patton, J.T., Davis, N.L., Wertz, G.W., 1984. N protein alone satisfies the
requirement for protein synthesis during RNA replication of vesicular
stomatitis virus. J. Virol. 49, 303–309.
Peluso, R.W., 1988. Kinetic, quantitative, and functional analysis of multiple
forms of the vesicular stomatitis virus nucleocapsid protein in infected cells.
J. Virol. 62, 2799–2807.Peluso, R.W., Moyer, S.A., 1988. Viral proteins required for the in vitro
replication of vesicular stomatitis virus defective interfering particle genome
RNA. Virology 162, 369–376.
Qanungo, K.R., Shaji, D., Mathur, M., Banerjee, A.K., 2004. Two RNA
polymerase complexes from vesicular stomatitis virus-infected cells that
carry out transcription and replication of genome RNA. Proc. Natl. Acad.
Sci. U.S.A. 101, 5952–5957.
Rao, B.L., Basu, A., Wairagkar, N.S., Gore, M.M., Arankalle, V.A., Thakare, J.
P., Jadi, R.S., Rao, K.A., Mishra, A.C., 2004. A large outbreak of acute
encephalitis with high fatality rate in children in Andhra Pradesh, India, in
2003, associated with Chandipura virus. Lancet 364, 869–874.
Richardson, J.C., Peluso, R.W., 1996. Inhibition of VSV genome RNA
replication but not transcription by monoclonal antibodies specific for the
viral P protein. Virology 216, 26–34.
Thomas, D., Newcomb, W.W., Brown, J.C., Wall, J.S., Hainfeld, J.F., Trus, B.
L., Steven, A.C., 1985. Mass and molecular composition of Vesicular
Stomatitis Virus: a scanning electron microscopy analysis. J. Virol. 54,
598–607.
Wertz, G.W., 1983. Replication of vesicular stomatitis virus defective interfering
particle RNA in vitro: transition from synthesis of defective interfering
leader RNA to synthesis of full-length defective interfering RNA. J. Virol.
46, 513–522.
Wertz, G.W., Levine, M., 1973. RNA synthesis by vesicular stomatitis virus
and a small plaque mutant: effects of cycloheximide. J. Virol. 12,
253–264.
Whelan, S.P., Wertz, G.W., 2002. Transcription and replication initiate at
different sites on the vesicular stomatitis virus genome. Proc. Natl. Acad.
Sci. U.S.A. 99, 9178–9183.
